RNAi was performed as previously described [43 (link)]. Briefly, oligonucleotides of siRNA for thymidylate synthase, ANT2, and PHB2 were obtained from Dharmacon (Lafayette, CO, USA). The following siRNAs were used: siTS #1 (J-004717-07; ON-TARGET plus Human TYMS (7298) siRNA), 5′-UGGGAGAUGCACAUAUUUA-3′; siTS #2 (J-004717-08; ON-TARGET plus Human TYMS (7298) siRNA), 5′-UCACAUCGAGCCACUGAAA-3′; siANT2 #1 (D-007486-03; siGENOME Human SLC25A5 (292) siRNA), 5′-CUGCAGAUAAGCAAUACAA-3′; siANT2 #2 (D-007486-04; siGENOME Human SLC25A5 (292) siRNA), 5′-GCAGAUAAGCAAUACAAAG-3′; siPHB2 #1 (J-018703-07; ON-TARGET plus Human PHB2 (11331) siRNA), 5′-CAUCAAACUUCGCAAGAUU-3′; siPHB2 #2 (J-018703-08; ON-TARGET plus Human PHB2 (11331) siRNA), 5′-CAGAAUAUCUCCAAGACGA-3′. The following negative control siRNAs were used: ON-TARGET plus Non-Targeting siRNA #3 (D-001810-03), 5′-UGGUUUACAUGUUUUCUGA-3′; siGENOME Non-Targeting siRNA #5 (D-001210-05), 5′-UGGUUUACAUGUCGACUAA-3′. Cells were transfected with 10 nM siTS and siPHB2 or 30 nM siANT2 using Lipofectamine RNAiMAX Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions.
+ Open protocol